4 February 2021

MaxCyte announces £40 million subscription

MaxCyte, Inc. (LSE: MXCT, MXCL), a global cell-engineering and life sciences company, has raised gross proceeds of £40 million (US$55 million) through a private placement of common stock. Subscribers included new investors D1 Capital Partners, T. Rowe Price, ArrowMark Partners, Baron Capital Group and First Light Asset Management, alongside existing investors Casdin Capital and Sofinnova Partners.

Doug Doerfler, President & Chief Executive Officer of MaxCyte, expressed his delight at the new life science specialist investors. He said that the financing would strengthen the company's balance sheet as it accelerates revenue growth in 2021 and marked a further step towards the company's goal to dual-list on Nasdaq in 2021.

There has been a 464.5% increase in the company's share price over the last 12 months, indicating strong investor interest in genomics and asset allocations to life sciences. MaxCyte's Flow Electroporation® Technology enables its biopharmaceutical partners to advance the development of innovative medicines, particularly in cell therapy.

Working with Panmure Gordon, LGB introduced investors to MaxCyte's fundraisings in 2017 and 2019. The fundraisings, which benefitted from EIS, were conducted at 275p and 170p per share respectively. The placing just announced was conducted at 700p.


Recent Articles

20 April 2021

Market Commentary - Q1 2021

Q1 2021 was marked in the UK, and the US which continues to set the tone for world markets, by cautious optimism that the vaccine rollout will work, and that economies will restart. Read more

News & Insights

19 April 2021

Exploring the options available to UK companies needing to refinance

Whilst government support has been helpful and likely kept many thousands of businesses afloat during the coronavirus crisis, it has burdened those businesses with debt that, even if it can be financed cheaply, will still have to be repaid.

Read more

News & Insights

14 April 2021

Sema Lease - Limit Increase

LGB Capital Markets arranged a £35 million Medium Term Note (MTN) programme for Sema Lease UK Limited (Sema), the short-term vehicle leasing provider.

Read more